IL94404A0 - Oxadiazole and its salts,their preparation and pharmaceutical compositions containing them - Google Patents
Oxadiazole and its salts,their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL94404A0 IL94404A0 IL94404A IL9440490A IL94404A0 IL 94404 A0 IL94404 A0 IL 94404A0 IL 94404 A IL94404 A IL 94404A IL 9440490 A IL9440490 A IL 9440490A IL 94404 A0 IL94404 A0 IL 94404A0
- Authority
- IL
- Israel
- Prior art keywords
- oxadiazole
- salts
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898911079A GB8911079D0 (en) | 1989-05-15 | 1989-05-15 | Therapeutic agents |
GB898923015A GB8923015D0 (en) | 1989-10-12 | 1989-10-12 | Therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
IL94404A0 true IL94404A0 (en) | 1991-03-10 |
Family
ID=26295353
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL94404A IL94404A0 (en) | 1989-05-15 | 1990-05-15 | Oxadiazole and its salts,their preparation and pharmaceutical compositions containing them |
Country Status (10)
Country | Link |
---|---|
US (1) | US5106853A (xx) |
EP (1) | EP0398629A3 (xx) |
JP (1) | JPH0363280A (xx) |
KR (1) | KR900018087A (xx) |
AU (1) | AU5506790A (xx) |
CA (1) | CA2016708A1 (xx) |
FI (1) | FI902415A0 (xx) |
IL (1) | IL94404A0 (xx) |
NO (1) | NO902156L (xx) |
PT (1) | PT94026A (xx) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8911080D0 (en) * | 1989-05-15 | 1989-06-28 | Merck Sharp & Dohme | Chemical process |
EP0456310A3 (en) * | 1990-05-09 | 1992-03-04 | Merck Sharp & Dohme Ltd. | Enantioselective synthesis of 3-substituted 1-azabicyclo (2.2.1)heptanes |
US5124460A (en) * | 1991-05-06 | 1992-06-23 | Merck Sharp & Dohme Ltd. | Enantioselective synthesis of 3-substituted 1-azabicyclo (2.2.1)heptanes |
US6060473A (en) * | 1993-04-01 | 2000-05-09 | Ucb S.A. - Dtb | 7-azabicyclo[2.2.1]-heptane and -heptene derivatives as cholinergic receptor ligands |
US5817679A (en) * | 1993-04-01 | 1998-10-06 | University Of Virginia | 7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands |
HUT74949A (en) * | 1993-09-10 | 1997-03-28 | Cytomed | Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists |
US6117889A (en) * | 1994-04-01 | 2000-09-12 | University Of Virginia | 7-Azabicyclo-[2.2.1]-heptane and -heptene derivatives as analgesics and anti-inflammatory agents |
GB9507203D0 (en) * | 1995-04-07 | 1995-05-31 | Smithkline Beecham Plc | Novel compounds |
WO2001002405A1 (en) * | 1999-07-06 | 2001-01-11 | Vertex Pharmaceuticals Incorporated | Quinuclidine derivatives for treatment of neurological disorders |
US8914114B2 (en) * | 2000-05-23 | 2014-12-16 | The Feinstein Institute For Medical Research | Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
AU2003217747A1 (en) * | 2002-02-26 | 2003-09-09 | North Shore-Long Island Jewish Research Insitute | Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
EP1734941A2 (en) * | 2004-03-25 | 2006-12-27 | The Feinstein Institute for Medical Research | Neural tourniquet |
US10912712B2 (en) | 2004-03-25 | 2021-02-09 | The Feinstein Institutes For Medical Research | Treatment of bleeding by non-invasive stimulation |
EP1833559B1 (en) | 2004-12-27 | 2010-11-24 | The Feinstein Institute for Medical Research | Treating inflammatory disorders by electrical vagus nerve stimulation |
US11207518B2 (en) | 2004-12-27 | 2021-12-28 | The Feinstein Institutes For Medical Research | Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway |
US8391970B2 (en) * | 2007-08-27 | 2013-03-05 | The Feinstein Institute For Medical Research | Devices and methods for inhibiting granulocyte activation by neural stimulation |
US9662490B2 (en) | 2008-03-31 | 2017-05-30 | The Feinstein Institute For Medical Research | Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug |
WO2009146030A1 (en) * | 2008-03-31 | 2009-12-03 | The Feinstein Institute For Medical Research | Methods and systems for reducing inflammation by neuromodulation of t-cell activity |
US20090275997A1 (en) * | 2008-05-01 | 2009-11-05 | Michael Allen Faltys | Vagus nerve stimulation electrodes and methods of use |
CN102215909B (zh) | 2008-11-18 | 2014-09-10 | 赛博恩特医疗器械公司 | 优化用于消炎刺激的电极放置的装置和方法 |
US8996116B2 (en) | 2009-10-30 | 2015-03-31 | Setpoint Medical Corporation | Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction |
US9211410B2 (en) | 2009-05-01 | 2015-12-15 | Setpoint Medical Corporation | Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation |
US8788034B2 (en) | 2011-05-09 | 2014-07-22 | Setpoint Medical Corporation | Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation |
CN102573986B (zh) | 2009-06-09 | 2016-01-20 | 赛博恩特医疗器械公司 | 用于无导线刺激器的具有袋部的神经封套 |
US11051744B2 (en) | 2009-11-17 | 2021-07-06 | Setpoint Medical Corporation | Closed-loop vagus nerve stimulation |
US9833621B2 (en) | 2011-09-23 | 2017-12-05 | Setpoint Medical Corporation | Modulation of sirtuins by vagus nerve stimulation |
EP3636314B1 (en) | 2009-12-23 | 2021-09-08 | Setpoint Medical Corporation | Neural stimulation devices and systems for treatment of chronic inflammation |
US9572983B2 (en) | 2012-03-26 | 2017-02-21 | Setpoint Medical Corporation | Devices and methods for modulation of bone erosion |
US11311725B2 (en) | 2014-10-24 | 2022-04-26 | Setpoint Medical Corporation | Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation |
US11406833B2 (en) | 2015-02-03 | 2022-08-09 | Setpoint Medical Corporation | Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator |
US10596367B2 (en) | 2016-01-13 | 2020-03-24 | Setpoint Medical Corporation | Systems and methods for establishing a nerve block |
CN114904142A (zh) | 2016-01-20 | 2022-08-16 | 赛博恩特医疗器械公司 | 迷走神经刺激的控制 |
US11471681B2 (en) | 2016-01-20 | 2022-10-18 | Setpoint Medical Corporation | Batteryless implantable microstimulators |
WO2017127758A1 (en) | 2016-01-20 | 2017-07-27 | Setpoint Medical Corporation | Implantable microstimulators and inductive charging systems |
US10583304B2 (en) | 2016-01-25 | 2020-03-10 | Setpoint Medical Corporation | Implantable neurostimulator having power control and thermal regulation and methods of use |
US11173307B2 (en) | 2017-08-14 | 2021-11-16 | Setpoint Medical Corporation | Vagus nerve stimulation pre-screening test |
US11660443B2 (en) | 2018-04-20 | 2023-05-30 | The Feinstein Institutes For Medical Research | Methods and apparatuses for reducing bleeding via electrical trigeminal nerve stimulation |
US11260229B2 (en) | 2018-09-25 | 2022-03-01 | The Feinstein Institutes For Medical Research | Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation |
KR20230012585A (ko) | 2020-05-21 | 2023-01-26 | 더 파인스타인 인스티튜츠 포 메디칼 리서치 | 미주 신경 자극을 위한 시스템들 및 방법들 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ219646A (en) * | 1986-03-27 | 1990-10-26 | Merck Sharp & Dohme | Oxadiazole derivatives of azacyclics for treating cns disorders |
NZ226000A (en) * | 1987-09-10 | 1991-06-25 | Merck Sharp & Dohme | Oxadiazolyl-azabicycloheptanes and pharmaceutical compositions |
NZ225999A (en) * | 1987-09-10 | 1992-04-28 | Merck Sharp & Dohme | Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions |
IL88846A0 (en) * | 1988-01-08 | 1989-07-31 | Merck Sharp & Dohme | Lipophilic oxadiazoles,their preparation and pharmaceutical compositions containing them |
-
1990
- 1990-05-09 US US07/520,891 patent/US5106853A/en not_active Expired - Fee Related
- 1990-05-14 PT PT94026A patent/PT94026A/pt not_active Application Discontinuation
- 1990-05-14 CA CA002016708A patent/CA2016708A1/en not_active Abandoned
- 1990-05-15 JP JP2123241A patent/JPH0363280A/ja active Pending
- 1990-05-15 AU AU55067/90A patent/AU5506790A/en not_active Abandoned
- 1990-05-15 FI FI902415A patent/FI902415A0/fi not_active Application Discontinuation
- 1990-05-15 NO NO90902156A patent/NO902156L/no unknown
- 1990-05-15 IL IL94404A patent/IL94404A0/xx unknown
- 1990-05-15 KR KR1019900006904A patent/KR900018087A/ko not_active Application Discontinuation
- 1990-05-15 EP EP19900305199 patent/EP0398629A3/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU5506790A (en) | 1990-11-15 |
KR900018087A (ko) | 1990-12-20 |
NO902156L (no) | 1990-11-16 |
NO902156D0 (no) | 1990-05-15 |
JPH0363280A (ja) | 1991-03-19 |
EP0398629A2 (en) | 1990-11-22 |
EP0398629A3 (en) | 1991-12-11 |
US5106853A (en) | 1992-04-21 |
PT94026A (pt) | 1991-01-08 |
CA2016708A1 (en) | 1990-11-15 |
FI902415A0 (fi) | 1990-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL94404A0 (en) | Oxadiazole and its salts,their preparation and pharmaceutical compositions containing them | |
IL87106A (en) | Oxadiazole derivatives, their preparation and pharmaceutical compositions containing them | |
IL95155A0 (en) | 1h-indazole-3-carboxamides,their preparation and pharmaceutical compositions containing them | |
IL95640A0 (en) | 1-cycloalkylpiperidines,their preparation and pharmaceutical compositions containing them | |
IL81930A0 (en) | Oxadiazoles,their preparation and pharmaceutical compositions containing them | |
IL91129A0 (en) | Aminomethyloxooxazolidinyl arylbenzene derivatives,their preparation and pharmaceutical compositions containing them | |
IL96577A0 (en) | Heterocyclic substituted acylaminothiazoles,their preparation and pharmaceutical compositions containing them | |
IL90245A0 (en) | Ethenediamine derivatives,their preparation and pharmaceutical compositions containing them | |
IL95045A0 (en) | Thienodiazepine derivatives,their preparation and pharmaceutical compositions containing them | |
IL94556A0 (en) | Hydroxypropylamines,their preparation and pharmaceutical compositions containing them | |
IL90864A0 (en) | Substituted 1,7-annelated 1h-indazoles,their preparation and pharmaceutical compositions containing them | |
IL94082A0 (en) | 3-n-substituted carbamoyl-indole derivatives,their preparation and pharmaceutical compositions containing them | |
IL92054A0 (en) | Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof,their preparation and pharmaceutical compositions containing them | |
IL87644A0 (en) | Oxadiazolyl-azabicycloheptanes,their preparation and pharmaceutical compositions containing them | |
IL95936A0 (en) | Phenethanolamine derivatives,their preparation and pharmaceutical compositions containing them | |
IL92710A (en) | 2-iminobenzothiazoline derivatives, their preparation and pharmaceutical compositions containing them | |
IL90315A0 (en) | Imidazoquinoxaline compounds,their preparation and pharmaceutical compositions containing them | |
IL91245A0 (en) | Benzopyranol derivatives,their preparation and pharmaceutical compositions containing them | |
IL91709A0 (en) | Substituted thienopyrans,their preparation and pharmaceutical compositions containing them | |
IL90002A0 (en) | Phosphonoalkylpurine derivatives,their preparation and pharmaceutical compositions containing them | |
IL92326A0 (en) | Substituted oxadiamino-butanes,their preparation and pharmaceutical compositions containing them | |
IL86478A0 (en) | Substituted vinylcephalosporins,their preparation and pharmaceutical compositions containing them | |
IL86926A0 (en) | 1h-pyrazole-1-alkanamides,their preparation and pharmaceutical compositions containing them | |
IL96216A0 (en) | Peptide derivatives,their preparation and pharmaceutical compositions containing them | |
IL95563A0 (en) | Substituted amino-pyridines,their preparation and pharmaceutical compositions containing them |